{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:54:03Z","timestamp":1755226443525,"version":"3.43.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00520-025-09746-6","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T02:20:49Z","timestamp":1752632449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes in patients with cancer and Gram-negative bloodstream infection: impact of carbapenem resistance"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1991-0923","authenticated-orcid":false,"given":"Patricia","family":"Volkow-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara\u00ed","family":"Pineda-Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-8573","authenticated-orcid":false,"given":"Pamela","family":"Alatorre-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8720-617X","authenticated-orcid":false,"given":"Beda","family":"Islas-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-1306","authenticated-orcid":false,"given":"Consuelo","family":"Vel\u00e1zquez-Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-8372","authenticated-orcid":false,"given":"Patricia","family":"Cornejo-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"9746_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-021-06243-z","volume":"21","author":"A Amanati","year":"2021","unstructured":"Amanati A, Sajedianfard S, Khajeh S, Ghasempour S, Mehrangiz S, Nematolahi S, Shahhosein Z (2021) Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect Dis 21:636. https:\/\/doi.org\/10.1186\/s12879-021-06243-z","journal-title":"BMC Infect Dis"},{"key":"9746_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02961-23","volume":"12","author":"C Lopera","year":"2024","unstructured":"Lopera C, Monz\u00f3 P, Aiello TF, Chumbita M, Peyrony O, Gallardo-Pizarro A, Pitart C, Cuervo G, Morata L, Bodro M, Herrera S, Del R\u00edo A, Mart\u00ednez JA, Soriano A, Puerta-Alcalde P, Garcia-Vidal C (2024) Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis. Microbiol Spectr 12. https:\/\/doi.org\/10.1128\/spectrum.02961-23","journal-title":"Microbiol Spectr"},{"key":"9746_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106284","volume":"57","author":"J Qu","year":"2021","unstructured":"Qu J, Feng C, Li H, Lv X (2021) Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. Int J Antimicrob Agents 57. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106284","journal-title":"Int J Antimicrob Agents"},{"key":"9746_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100399","volume":"12","author":"B Awada","year":"2024","unstructured":"Awada B, Abarca J, Mumtaz S, Al-Khirbash A, Al-Sayegh H, Milupi M, Garcia AE, Al Harthy M, Al Qarshoubi I, Al Baimani K, Varghese GM (2024) Predictors and outcomes of multi-drug-resistant gram-negative bacteremia in patients with cancer: a retrospective cohort study at a tertiary cancer center in Oman. IJID Reg 12. https:\/\/doi.org\/10.1016\/j.ijregi.2024.100399","journal-title":"IJID Reg"},{"key":"9746_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","volume":"69","author":"M Marin","year":"2014","unstructured":"Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Calvo M, Arnan M, Carratal\u00e0 J (2014) Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect 69:417\u2013423. https:\/\/doi.org\/10.1016\/j.jinf.2014.05.018","journal-title":"J Infect"},{"key":"9746_CR6","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00277-018-3423-5","volume":"97","author":"S Scheich","year":"2018","unstructured":"Scheich S, Weber S, Reinheimer C, Wichelhaus TA, Hogardt M, Kempf VAJ, Kessel J, Serve H, Steffen B (2018) Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies. Ann Hematol 97:2225\u20132234. https:\/\/doi.org\/10.1007\/s00277-018-3423-5","journal-title":"Ann Hematol"},{"key":"9746_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/sur.2009.084","volume":"11","author":"KC Sihler","year":"2010","unstructured":"Sihler KC, Chenoweth C, Zalewski C, Wahl W, Hyzy R, Napolitano LM (2010) Catheter-related vs. catheter-associated blood stream infections in the intensive care unit: incidence, microbiology, and implications. Surg Infect (Larchmt) 11:529\u2013534. https:\/\/doi.org\/10.1089\/sur.2009.084","journal-title":"Surg Infect (Larchmt)"},{"key":"9746_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345. https:\/\/doi.org\/10.1086\/599376","journal-title":"Clin Infect Dis"},{"key":"9746_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/671281","volume":"34","author":"I See","year":"2013","unstructured":"See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND (2013) Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 34:769\u2013776. https:\/\/doi.org\/10.1086\/671281","journal-title":"Infect Control Hosp Epidemiol"},{"key":"9746_CR10","unstructured":"Smith DA, Nehring SM (2023) Bacteremia. StatPearls [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441979\/. Accessed 25 Jan 2025"},{"key":"9746_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1098\/rstb.1980.0049","volume":"289","author":"RP Ambler","year":"1980","unstructured":"Ambler RP (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289:321\u2013331. https:\/\/doi.org\/10.1098\/rstb.1980.0049","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9746_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2018.03.022","volume":"71","author":"B Islas-Mu\u00f1oz","year":"2018","unstructured":"Islas-Mu\u00f1oz B, Volkow-Fern\u00e1ndez P, Ibanes-Guti\u00e9rrez C, Villamar-Ram\u00edrez A, Vilar-Compte D, Cornejo-Ju\u00e1rez P (2018) Bloodstream infections in cancer patients. Risk factors associated with mortality. Int J Infect Dis 71:59\u201364. https:\/\/doi.org\/10.1016\/j.ijid.2018.03.022","journal-title":"Int J Infect Dis"},{"key":"9746_CR13","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1093\/jac\/dkv218","volume":"70","author":"N Andria","year":"2015","unstructured":"Andria N, Henig O, Kotler O, Domchenko A, Oren I, Zuckerman T, Ofran Y, Fraser D, Paul M (2015) Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study. J Antimicrob Chemother 70:3146\u20133153. https:\/\/doi.org\/10.1093\/jac\/dkv218","journal-title":"J Antimicrob Chemother"},{"key":"9746_CR14","doi-asserted-by":"publisher","unstructured":"Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, et al; Hematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry \u2013 Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy (2023) Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey. Int J Antimicrob Agents 61: 106806. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106806","DOI":"10.1016\/j.ijantimicag.2023.106806"},{"key":"9746_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234684","volume":"15","author":"P Cornejo-Ju\u00e1rez","year":"2020","unstructured":"Cornejo-Ju\u00e1rez P, Cevallos MA, Castro-Jaimes S, Castillo-Ram\u00edrez S, Vel\u00e1zquez-Acosta C, Mart\u00ednez-Oliva D, P\u00e9rez-Oseguera A, Rivera-Buend\u00eda F, Volkow-Fern\u00e1ndez P (2020) High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital. PLoS ONE 15. https:\/\/doi.org\/10.1371\/journal.pone.0234684","journal-title":"PLoS ONE"},{"key":"9746_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248614","volume":"16","author":"E Garza-Gonz\u00e1lez","year":"2021","unstructured":"Garza-Gonz\u00e1lez E, Bocanegra-Ibarias P, Bobadilla-Del-Valle M, Ponce-de-Le\u00f3n-Gardu\u00f1o LA, Esteban-Kenel V, Silva-S\u00e1nchez J et al (2021) Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: results from the infivar network. PLoS ONE 16. https:\/\/doi.org\/10.1371\/journal.pone.0248614","journal-title":"PLoS ONE"},{"key":"9746_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Nosari A, Caira M, Spadea A, Busca A, Vianelli N, Tumbarello M; HeMABIS Registry\u2014SEIFEM Group, Italy","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Nosari A, Caira M, Spadea A, Busca A, Vianelli N, Tumbarello M; HeMABIS Registry\u2014SEIFEM Group, Italy (2015) Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect 21:337\u2013343. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022","journal-title":"Clin Microbiol Infect"},{"key":"9746_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2023.102758","volume":"27","author":"AP Schonardie","year":"2023","unstructured":"Schonardie AP, Beck E, Rigatto MH (2023) Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia. Braz J Infect Dis 27. https:\/\/doi.org\/10.1016\/j.bjid.2023.102758","journal-title":"Braz J Infect Dis"},{"key":"9746_CR19","doi-asserted-by":"publisher","unstructured":"De la Rosa-Riestra S, Mart\u00ednez P\u00e9rez-Crespo PM, P\u00e9rez Rodr\u00edguez MT, Sousa A, Goikoetxea J, Reguera Iglesias JM, et al; PROBAC group (2024) Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: results from the prospective, multicentre cohort PROBAC. Int J Infect Dis 145: 107072. https:\/\/doi.org\/10.1016\/j.ijid.2024.107072","DOI":"10.1016\/j.ijid.2024.107072"},{"key":"9746_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","volume":"73","author":"MJ Satlin","year":"2016","unstructured":"Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, Chen L, Kreiswirth BN, Walsh TJ, Seo SK (2016) Bacteremia due to carbapenem-resistant Enterobacterales in neutropenic patients with hematologic malignancies. J Infect 73:336\u2013345. https:\/\/doi.org\/10.1016\/j.jinf.2016.07.002","journal-title":"J Infect"},{"key":"9746_CR21","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/biomedicines10123049","volume":"10","author":"M Brauncajs","year":"2022","unstructured":"Brauncajs M, Bielec F, Macieja A, Pastuszak-Lewandoska D (2022) Carbapenem-resistant Gram-negative fermenting and non-fermenting rods isolated from hospital patients in Poland-what are they susceptible to? Biomedicines 10:3049. https:\/\/doi.org\/10.3390\/biomedicines10123049","journal-title":"Biomedicines"},{"key":"9746_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ijantimicag.2017.12.012","volume":"51","author":"CA Vargas-Alzate","year":"2018","unstructured":"Vargas-Alzate CA, Higuita-Guti\u00e9rrez LF, L\u00f3pez-L\u00f3pez L, Cienfuegos-Gallet AV, Jim\u00e9nez Quiceno JN (2018) High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region. Int J Antimicrob Agents 51:601\u2013607. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.12.012","journal-title":"Int J Antimicrob Agents"},{"key":"9746_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13855","volume":"17","author":"P Karnmueng","year":"2024","unstructured":"Karnmueng P, Montakantikul P, Paiboonvong T, Plongla R, Chatsuwan T, Chumnumwat S (2024) Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48. Clin Transl Sci 17. https:\/\/doi.org\/10.1111\/cts.13855","journal-title":"Clin Transl Sci"},{"key":"9746_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/14787210.2022.2128764","volume":"20","author":"B Isler","year":"2022","unstructured":"Isler B, Aslan AT, Akova M, Harris P, Paterson DL (2022) Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections. Expert Rev Anti Infect Ther 20:1389\u20131400. https:\/\/doi.org\/10.1080\/14787210.2022.2128764","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T02:20:51Z","timestamp":1752632451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["9746"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09746-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Ethics Committee Board (INCan\/2024\/073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived, as no intervention was involved, and no patient-identifiable information was included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"694"}}